2Eyes Vision

2Eyes Vision

Verified
Technological and clinical validation of the SimVis technology to treat presbyopia with multifocal contact lenses.

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR201820192020202120222023
Revenues000000000000000000000000
% growth-166 %(66 %)(6 %)207 %58 %
EBITDA000000000000000000000000
% EBITDA margin55 %(168 %)(445 %)(1027 %)(559 %)-
Profit000000000000000000000000
% profit margin(5 %)(150 %)(403 %)(1136 %)(572 %)-
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
N/A

$0.0

round
investor investor

$0.0

round
investor

$0.0

round
investor

$0.0

round
investor investor investor investor investor

$0.0

round
*

€900k

Late VC
Total Funding000k

Recent News about 2Eyes Vision

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.